Africa: Medical Product Alert N °4/2022 - Falsified DYSPORT
[WHO] Alert Summary (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 22, 2022 Category: African Health Source Type: news
FDA Expands Dysport Use for Cerebral Palsy-Related Spasticity FDA Expands Dysport Use for Cerebral Palsy-Related Spasticity
Dysport (abobotulinumtoxinA) has been approved for expanded use to treat upper- and lower-limb spasticity, including that caused by cerebral palsy, for patients 2 and older.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 14, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Ipsen Announces Updated Indication for Dysport (abobotulinumtoxinA) for the Treatment of Spasticity in Children
CAMBRIDGE, Mass.--(BUSINESS WIRE) July 09, 2020 --Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved the expanded use of Dysport... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 9, 2020 Category: Drugs & Pharmacology Source Type: news
Ipsen and Saol partner to co-promote Dysport in US
The US affiliate of French pharmaceutical company Ipsen has entered an exclusive, three-year agreement with Saol Therapeutics to promote Dysport (abobotulinumtoxinA) for approved therapeutic indications in adult spasticity and pediatric lower limb sp … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 2, 2017 Category: Pharmaceuticals Source Type: news
Dysport (Abobotulinumtoxin A Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 26, 2017 Category: Drugs & Pharmacology Source Type: news
Jailed Leawood businesswoman faces new charges
A Leawood woman in prison for tax evasion may have her stay extended.
Kathleen Stegman, former owner of Midwest Medical Aesthetics Center Inc. in Leawood, was charged Friday with importing misbranded drugs. Prosecutors allege that Stegman obtained Botox, Dysport, Restylane, Perlane and Sculptra from foreign sources. In total, they claim she imported $194,000 of the drugs, which did not meet U.S. Food and Drug Administration labeling requirements.
Stegman was sentenced in October to 51 months in… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 19, 2017 Category: Health Management Authors: Brian Kaberline Source Type: news
Jailed Leawood businesswoman faces new charges
A Leawood woman in prison for tax evasion may have her stay extended.
Kathleen Stegman, former owner of Midwest Medical Aesthetics Center Inc. in Leawood, was charged Friday with importing misbranded drugs. Prosecutors allege that Stegman obtained Botox, Dysport, Restylane, Perlane and Sculptra from foreign sources. In total, they claim she imported $194,000 of the drugs, which did not meet U.S. Food and Drug Administration labeling requirements.
Stegman was sentenced in October to 51 months in… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 19, 2017 Category: Biotechnology Authors: Brian Kaberline Source Type: news
Ipsen Announces FDA approval of Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
June 16, 2017 -- Ipsen (Euronext: IPN; ADR: IPSEY) (Ipsen) today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved use of Dysport (abobotulinumtoxinA) for injection for the treatment of spasticity in adults, based... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 16, 2017 Category: Drugs & Pharmacology Source Type: news
Everything You Ever Wanted To Know About Getting Botox In Your Groin
Most of us are familiar with botulinum toxin injections (commonly known by their brand names as Botox, Dysport and Xeomin) to erase facial wrinkles.
But Botox can also help people who suffer from excessive sweating, which is known as hyperhidrosis. In order to put a halt to sweating, it’s become increasingly more common to receive Botox injections in the armpits. And now, people are getting injections in their groin, as well.
HuffPost recently spoke with Dr. John H.Tu, M.D. from the University of Rochester Department of Dermatology and dermatologist for Dermatology Associates of Rochester. He fi...
Source: Healthy Living - The Huffington Post - June 5, 2017 Category: Consumer Health News Source Type: news
Grand jury indicts "fake doctor" of operating illegal Botox and laser clinics in Tempe, Scottsdale
A State Grand Jury indicted Craig Allen Scherf for allegedly operating illegal Botox and laser clinics in Tempe and Scottsdale.
Scherf is not licensed by the Arizona Medical Board or any other agency governing the practice of medicine in Arizona, according to Arizona Attorney General Mark Brnovich.
In January, investigators with the Arizona Attorney General's Office learned that Scherf was allegedly pretending to be a lic ensed doctor while providing Botox, Dysport and body laser treatments at a… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 21, 2017 Category: Biotechnology Authors: Angela Gonzales Source Type: news
Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Paediatric Patients
Dysport (abobotulinumtoxinA) is an injectable formulation developed by Ipsen Biopharmaceuticals for the treatment of lower limb spasticity in paediatric patients aged two years or older. (Source: Drug Development Technology)
Source: Drug Development Technology - August 25, 2016 Category: Pharmaceuticals Source Type: news
NeuroBreak: Alzheimer's $$; ALS Genes; Dysport for Kids
(MedPage Today) -- News and commentary from the world of neurology and neuroscience (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - August 9, 2016 Category: Psychiatry Source Type: news
FDA Clears Dysport for Lower-Limb Spasticity in Kids FDA Clears Dysport for Lower-Limb Spasticity in Kids
Dysport is the first, and only, FDA-approved botulinum toxin for the treatment of pediatric lower-limb spasticity.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 3, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Pediatric Patients Aged Two and Older
BASKING RIDGE, N.J., Aug. 1, 2016 /PRNewswire/ -- Ipsen Biopharmaceuticals, Inc., a subsidiary of Ipsen SA (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 1, 2016 Category: Drugs & Pharmacology Source Type: news
Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport(R) (Abobotulinumtoxin A) for the Treatment of Lower Limb Spasticity in Pediatric Patients Aged Two and Older
BASKING RIDGE, N.J., Aug. 1, 2016 -- (Healthcare Sales & Marketing Network) -- Ipsen Biopharmaceuticals, Inc., a subsidiary of Ipsen SA (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that the U.S. Food and Drug Administration (FDA) has approved its ... Biopharmaceuticals, FDA Ipsen Biopharmaceuticals, Dysport, abobotulinumtoxin A, botulinum toxin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 1, 2016 Category: Pharmaceuticals Source Type: news
